There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cara Therapeutics
Tag: CARA
Canaccord Genuity Believes Cara Therapeutics (NASDAQ: CARA) Still Has Room to Grow
In a report released today, Arlinda Lee from Canaccord Genuity maintained a Buy rating on Cara Therapeutics (CARA – Research
H.C. Wainwright Sticks to Its Buy Rating for Cara Therapeutics (CARA)
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Cara Therapeutics (CARA – Research
A Director at Cara Therapeutics (NASDAQ: CARA) is Selling Shares
On November 19, a Director at Cara Therapeutics (CARA – Research Report), Martin Vogelbaum, sold shares of CARA for $96.54K.
Cara Therapeutics (CARA) Received its Third Buy in a Row
After H.C. Wainwright and Needham gave Cara Therapeutics (NASDAQ: CARA) a Buy rating last month, the company received another Buy,
Cara Therapeutics (CARA) Gets a Buy Rating from Needham
In a report released today, Alan Carr from Needham reiterated a Buy rating on Cara Therapeutics (CARA – Research Report),
H.C. Wainwright Reiterates a Buy Rating on Cara Therapeutics (CARA)
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Cara Therapeutics (CARA – Research Report) today and set a